1.
Cortelezzi A, Pasquini M, Sarina B, Bertani G, Grifoni F, Colombi M, Deliliers GL. A pilot study of low-dose subcutaneous alemtuzumab therapy for patients with hemotherapy-refractory chronic lymphocytic leukemia. Haematologica [Internet]. 2005Mar.1 [cited 2026Nov.7];90(3):410-2. Available from: https://haematologica.org/article/view/3447